ECHA’s RAC Adopts Opinions on Classification and Labeling Proposals

The Committee for Risk Assessment (RAC) of ECHA has adopted opinions on the proposals for classification and labellng across Europe of three chemical substances as carcinogen, mutagen or toxic for reproduction The substances are:

• Indium phosphide: The classification is currently not harmonized at EU level. RAC agreed with the proposal from France that the classification of the substance should be harmonized as a carcinogen and toxic for reproduction. RAC also proposed a classification for repeated dose toxicity from inhalation exposure. Indium phosphide is, for example, used as a semiconductor in the electronics industry.

• Di-tert-butyl peroxide - DTBP: DTBP is currently classified at EU level for certain physico-chemical hazards. RAC agreed with the proposal from France to also classify it as a mutagen. DTBP is typically used by industry as an additive in polymerisation reactions.

• Trixylyl phosphate: The classification is currently not harmonised at EU level. RAC agreed with the proposal from the Netherlands for a harmonised classification of toxic for reproduction. Trixylyl phosphate is mainly used as a fire resistant hydraulic fluid, for example in industrial power generators.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Cannabis Extraction — Temperature Control Systems in Action

Cannabis Extraction — Temperature Control Systems in Action

Cannabis is a crop that has been cultivated for thousands of years and contains many pharmacologically active substances.

most read

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.